Cell Source, Inc.
CLCS
$0.82
$0.000.00%
OTC PK
| 03/31/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | 2.13M | 2.14M | 2.14M | 2.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 4.03M | 4.19M | 4.19M | 3.91M |
| Operating Income | -- | -4.03M | -4.19M | -4.19M | -3.91M |
| Income Before Tax | -- | -5.23M | -5.15M | -5.15M | -4.91M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -5.23 | -5.15 | -5.15 | -4.91 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -5.23M | -5.15M | -5.15M | -4.91M |
| EBIT | -- | -4.03M | -4.19M | -4.19M | -3.91M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | -0.16 | -0.16 | -0.16 | -0.16 |
| Normalized Basic EPS | -- | -0.08 | -0.08 | -0.08 | -0.08 |
| EPS Diluted | -- | -0.16 | -0.16 | -0.16 | -0.16 |
| Normalized Diluted EPS | -- | -0.08 | -0.08 | -0.08 | -0.08 |
| Average Basic Shares Outstanding | -- | 162.62M | 158.39M | 158.39M | 154.58M |
| Average Diluted Shares Outstanding | -- | 162.62M | 158.39M | 158.39M | 154.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |